GO:0015866 ADP transport: Mitochondrial Energy Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015866 ADP transport describes the directed movement of adenosine diphosphate (ADP) into, out of, or within a cell by transporters or pores.
• The mitochondrial ADP/ATP carrier (SLC25A4/AAC) is the best-characterized ADP transporter, exchanging cytosolic ADP for matrix ATP across the inner mitochondrial membrane.
• The ADP/ATP carrier operates by an alternating-access mechanism in which a single substrate-binding site is exposed alternately to each side of the membrane.
• Recent structural work shows that the carrier also transports protons, coupling ADP/ATP exchange to proton movement.
• ADP transport is essential for oxidative phosphorylation because it supplies ADP to the matrix and exports newly synthesized ATP to the cytosol.
• Dysregulation of ADP transport is linked to mitochondrial diseases, metabolic disorders, and cancer metabolism.
Description
ADP transport (GO:0015866) is the biological process by which adenosine diphosphate (ADP) is moved into, out of, or within a cell by means of a transporter or pore. ADP is a central metabolite in cellular energy metabolism, and its subcellular distribution directly controls the rate of oxidative phosphorylation and many biosynthetic reactions. The most extensively studied ADP transport system is the mitochondrial ADP/ATP carrier (AAC, also known as SLC25A4 or ANT1), which exchanges cytosolic ADP for matrix ATP across the inner mitochondrial membrane. This exchange is one of the most abundant transport activities in mitochondria and is essential for maintaining the cellular energy balance.
ADP transport At A Glance
| GO ID | GO:0015866 |
|---|---|
| GO term | ADP transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Movement of ADP across cellular membranes by transporters or pores |
| Major transporter | Mitochondrial ADP/ATP carrier (SLC25A4/AAC/ANT) |
| Cellular location | Inner mitochondrial membrane, and other organelle membranes |
| Directionality | Exchange of cytosolic ADP for matrix ATP (antiport) |
| Linked process | Oxidative phosphorylation and cellular energy metabolism |
What Is GO:0015866?
According to the Gene Ontology, ADP transport (GO:0015866) is the directed movement of ADP, adenosine diphosphate, into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses both protein-mediated translocation across membranes and, in broader usage, the movement of ADP between cellular compartments. The term is a biological process and does not imply a specific molecular mechanism; it can be carried out by secondary active transporters, exchangers, or channels.
Why Is ADP transport Important in Cell Biology?
ADP transport is a rate-limiting step in oxidative phosphorylation because the mitochondrial ATP synthase requires a continuous supply of ADP and releases ATP that must be exported to the cytosol. The ADP/ATP carrier is one of the most abundant proteins in the inner mitochondrial membrane, and its activity determines the efficiency of energy conversion in eukaryotic cells. Beyond bioenergetics, ADP transport influences apoptosis, calcium signaling, and metabolic reprogramming in cancer. Consequently, understanding ADP transport is fundamental to mitochondrial physiology and to the pathophysiology of numerous human diseases.
• Supplies ADP to the mitochondrial matrix for ATP synthesis by oxidative phosphorylation.
• Exports newly synthesized ATP from mitochondria to power cytosolic processes.
• Maintains cellular energy homeostasis and the ATP/ADP ratio.
• Regulates mitochondrial membrane potential and reactive oxygen species production.
• Plays a role in the mitochondrial permeability transition pore and apoptosis.
• Is a target for metabolic diseases and cancer therapeutics.
• Provides a model system for understanding membrane transport mechanisms.
• Is conserved from yeast to humans, enabling genetic studies.
• Dysfunction is linked to mitochondrial myopathies and neuropathies.
• Its proton transport activity couples energy metabolism to pH regulation.
What Happens During ADP transport?
Substrate recognition and binding
In simple terms: The transporter grabs ADP on one side of the membrane.
The mitochondrial ADP/ATP carrier (AAC) binds ADP from the cytosol with high specificity. Structural studies show that a single substrate-binding site is located in the central cavity of the carrier, formed by three symmetric sequence repeats. The binding site contains conserved positively charged residues that interact with the phosphate groups of ADP, while hydrophobic residues accommodate the adenine ring. This binding step is the first committed step in the transport cycle and determines the selectivity for ADP over ATP.
Conformational transition (alternating access)
In simple terms: The transporter changes shape to open toward the other side.
Upon ADP binding, the carrier undergoes a large conformational change that switches it from the cytosolic-facing (c-state) to the matrix-facing (m-state) conformation. This alternating-access mechanism involves the movement of three gate elements and a rotation of the carrier's domains. The transition is rate-limiting and is driven by the binding energy of the substrate and the membrane potential. Recent structures captured both states and revealed that the carrier operates as a monomer, not a dimer as previously thought.
ADP release and ATP counter-exchange
In simple terms: ADP is released inside, and ATP is picked up to be carried out.
In the matrix-facing conformation, the binding site opens to the matrix, and ADP is released. The carrier then binds matrix ATP, which triggers the reverse conformational change to the cytosolic-facing state, exporting ATP to the cytosol. This strict exchange mechanism (antiport) ensures that ADP and ATP are transported in opposite directions, coupling the import of ADP to the export of ATP. The exchange is electrogenic because ATP and ADP have different charges, and it is influenced by the membrane potential.
Proton transport and regulatory coupling
In simple terms: The transporter also moves protons, which helps regulate the process.
Recent evidence shows that the mitochondrial ADP/ATP carrier also transports protons, and this proton movement is an integral part of its function. The proton flux is coupled to the ADP/ATP exchange and may contribute to the regulation of the carrier's activity in response to the proton motive force. This dual transport activity links ADP transport to cellular pH and mitochondrial signaling. The exact stoichiometry and physiological role of proton transport are still under investigation.
Key Genes Involved in GO:0015866 ADP transport
The following genes encode proteins that directly mediate or regulate ADP transport, with emphasis on the mitochondrial carrier family and associated factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A4 (ANT1) | Mitochondrial ADP/ATP carrier; exchanges cytosolic ADP for matrix ATP | Most studied ADP transporter; mutations cause mitochondrial myopathy and cardiomyopathy |
| SLC25A5 (ANT2) | Mitochondrial ADP/ATP carrier isoform | Highly expressed in proliferating cells; linked to cancer metabolism |
| SLC25A6 (ANT3) | Mitochondrial ADP/ATP carrier isoform | Ubiquitously expressed; may have distinct regulatory roles |
| SLC25A31 (ANT4) | Mitochondrial ADP/ATP carrier isoform | Testis-specific; involved in spermatogenesis |
| SLC35B1 | Endoplasmic reticulum ATP/ADP transporter | Mediates stepwise ATP translocation into the ER; involved in ER homeostasis |
| VDAC1 | Outer mitochondrial membrane channel | Allows ADP/ATP passage across the outer membrane |
| VDAC2 | Outer mitochondrial membrane channel | Regulates metabolite flux and apoptosis |
| VDAC3 | Outer mitochondrial membrane channel | Less characterized; may modulate transport |
| ATP5F1A | ATP synthase subunit | Produces ATP from ADP in the matrix; indirectly affects ADP transport |
| ATP5F1B | ATP synthase subunit | Catalytic subunit of ATP synthase |
| PPIF (Cyclophilin D) | Regulates mitochondrial permeability transition pore | Modulates ADP/ATP transport under stress |
| CKMT1 | Creatine kinase, mitochondrial | Buffers ADP/ATP near mitochondria |
| AK2 | Adenylate kinase 2 | Interconverts ADP and ATP in the intermembrane space |
| SLC25A1 | Mitochondrial citrate carrier | Indirectly affects energy metabolism |
| SLC25A3 | Mitochondrial phosphate carrier | Supplies phosphate for ATP synthesis |
| SLC25A10 | Mitochondrial dicarboxylate carrier | Links to energy metabolism |
| SLC25A12 | Mitochondrial aspartate/glutamate carrier | Supports malate-aspartate shuttle |
| SLC25A13 | Mitochondrial aspartate/glutamate carrier | Supports malate-aspartate shuttle |
How Is ADP transport Regulated?
ADP transport is regulated at multiple levels. The mitochondrial ADP/ATP carrier is subject to transcriptional control by nuclear respiratory factors and PGC-1alpha in response to energy demand. Post-translational modifications, including acetylation and phosphorylation, can modulate carrier activity. The carrier's function is also influenced by the lipid composition of the inner mitochondrial membrane, particularly cardiolipin, which is required for its stability and activity. Additionally, the proton transport activity of the carrier may be regulated by the proton motive force and pH. In the endoplasmic reticulum, SLC35B1-mediated ATP/ADP transport is regulated by the ER luminal ATP/ADP ratio and may be coupled to protein folding.
ADP transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A4 | Mitochondrial myopathy, cardiomyopathy | Knockout mouse, patient iPSC-derived cardiomyocytes |
| SLC25A5 | Cancer metabolism, proliferation | Cancer cell lines with knockdown/overexpression |
| SLC35B1 | ER stress, metabolic disorders | CRISPR knockout in HEK293 cells |
| VDAC1 | Apoptosis, cancer | Knockout mice, cancer xenografts |
| PPIF | Mitochondrial permeability transition, ischemia-reperfusion injury | Knockout mice |
Mitochondrial myopathies and cardiomyopathies
Mutations in SLC25A4 (ANT1) cause autosomal dominant mitochondrial myopathy and cardiomyopathy, characterized by muscle weakness, exercise intolerance, and cardiac dysfunction. These mutations impair ADP/ATP exchange, leading to energy failure in highly oxidative tissues. Experimental models include knockout mice and patient-derived fibroblasts, which show reduced mitochondrial respiration.
Cancer metabolism
Altered expression of ADP/ATP carrier isoforms, particularly SLC25A5 (ANT2), is observed in many cancers and supports the high metabolic demand of proliferating cells. Targeting ADP transport may disrupt cancer cell bioenergetics and is being explored as a therapeutic strategy. However, the precise role of individual isoforms in tumorigenesis requires further study.
Neurodegeneration
Impaired mitochondrial ADP transport has been implicated in neurodegenerative diseases such as Parkinson's and Alzheimer's, where energy deficits contribute to neuronal loss. The ADP/ATP carrier is also involved in the mitochondrial permeability transition, a key event in neuronal cell death. Model systems include neuronal cell lines and transgenic mice with carrier mutations.
ER stress and metabolic disorders
SLC35B1-mediated ATP/ADP transport into the endoplasmic reticulum is important for ER function, and its dysfunction may contribute to ER stress-related diseases. However, direct links to human disease are still emerging.
From ADP transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC25A4 impair oxidative phosphorylation? | SLC25A4 knockout cell lines (e.g., HEK293, HeLa) |
| How do point mutations in SLC25A4 affect ADP transport? | Point-mutation knock-in via CRISPR in patient fibroblasts |
| Can tagging SLC25A4 reveal its subcellular localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of SLC25A5 alter cancer cell metabolism? | Doxycycline-inducible overexpression in cancer cells |
| What is the role of SLC35B1 in ER ATP transport? | SLC35B1 knockout and rescue with wild-type or mutant |
| How does proton transport by AAC affect mitochondrial function? | Point mutations in protonatable residues followed by Seahorse assay |
How to Study the ADP transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse respirometry | Oxygen consumption rate, ATP production | Functional assessment of ADP transport mutants |
| Radioactive nucleotide transport assay | ADP/ATP exchange activity | Kinetic analysis of carrier proteins |
| Cryo-EM | High-resolution structure of carrier | Mechanistic studies of alternating access |
| Fluorescent ATP/ADP sensors | Real-time nucleotide dynamics | Live-cell imaging of compartmental ADP |
| Blue native PAGE | Carrier complex assembly | Detection of dimeric/monomeric states |
| Proteoliposome reconstitution | Transport activity of purified protein | In vitro mechanistic studies |
| CRISPR knockout screening | Gene essentiality and metabolic dependencies | Identification of ADP transport regulators |
| RNA-seq | Transcriptional changes upon transport perturbation | Pathway analysis in disease models |
Respirometry and Seahorse analysis
Oxygen consumption rate (OCR) measurements using Seahorse or Clark-type electrodes assess mitochondrial respiration, which depends on ADP transport. Cells with knockout or mutant carriers show reduced maximal respiration and ATP production. This method is standard for evaluating the functional impact of ADP transport perturbations.
Mitochondrial swelling and transport assays
Isolated mitochondria can be used to measure ADP/ATP exchange activity by monitoring swelling in ammonium salts or using radioactive nucleotides. These assays directly quantify transport kinetics and substrate specificity. They are complemented by proteoliposome reconstitution of purified carrier.
Structural biology (cryo-EM and X-ray crystallography)
High-resolution structures of the ADP/ATP carrier in different conformations have been solved by X-ray crystallography and cryo-electron microscopy. These structures reveal the alternating-access mechanism and substrate-binding site. Structural studies are essential for understanding how mutations affect transport.
Live-cell imaging and fluorescent sensors
Genetically encoded fluorescent sensors for ATP/ADP (e.g., PercevalHR, ATeam) allow real-time monitoring of nucleotide dynamics in live cells. Targeting these sensors to mitochondria or ER enables compartment-specific measurements. This approach is powerful for studying ADP transport in situ.
How CRISPR Can Be Used to Study GO:0015866 ADP transport
Knockout
CRISPR knockout of SLC25A4 or other ADP transport genes in cell lines (e.g., HEK293, HeLa) abolishes specific carrier activity and causes severe bioenergetic defects. These models are used to study the contribution of individual isoforms to mitochondrial respiration and to identify compensatory pathways. Knockout of SLC35B1 impairs ER ATP transport and induces ER stress.
Point Mutation
CRISPR-mediated point mutations can recreate disease-associated missense mutations in SLC25A4, such as those found in mitochondrial myopathy patients. These knock-in models allow precise assessment of how single amino acid changes affect ADP binding, transport kinetics, and cellular metabolism. They are valuable for validating structural predictions.
Knock-in
Knock-in of epitope tags (e.g., HA, GFP) or fluorescent proteins at the endogenous SLC25A4 locus enables visualization and immunoprecipitation of the carrier in its native context. This approach avoids overexpression artifacts and provides physiological expression levels. Knock-in of inducible degron tags allows rapid depletion of the carrier to study acute effects.
Overexpression
Overexpression of ADP/ATP carrier isoforms (e.g., SLC25A5) in cancer cell lines is used to study their role in proliferation and metabolic reprogramming. Inducible systems allow controlled expression to avoid toxicity. Overexpression of SLC35B1 can enhance ER ATP import and may protect against ER stress.
How EDITGENE Supports ADP transport Research
Researchers studying ADP transport-related genes often need to determine whether a candidate gene is causally involved in mitochondrial bioenergetics, metabolite exchange, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for ADP transport research.
Frequently Asked Questions About ADP transport
What is ADP transport (GO:0015866)?
ADP transport is the biological process of moving adenosine diphosphate (ADP) into, out of, or within a cell by means of a transporter or pore.
What genes are involved in ADP transport?
Key genes include SLC25A4, SLC25A5, SLC25A6, SLC25A31 (mitochondrial ADP/ATP carriers), SLC35B1 (ER transporter), and VDAC1-3 (outer membrane channels).
What is the mitochondrial ADP/ATP carrier?
The mitochondrial ADP/ATP carrier (AAC, SLC25A4) is an inner membrane protein that exchanges cytosolic ADP for matrix ATP, a critical step in oxidative phosphorylation.
How does the ADP/ATP carrier work?
It operates by an alternating-access mechanism, binding ADP on one side, changing conformation, and releasing it on the other side while transporting ATP in the opposite direction.
Why is ADP transport important for energy metabolism?
ADP transport supplies the substrate for ATP synthase and exports ATP to the cytosol, maintaining cellular energy balance.
What diseases are linked to defective ADP transport?
Mutations in SLC25A4 cause mitochondrial myopathy and cardiomyopathy; altered ADP transport is also implicated in cancer and neurodegeneration.
Does the ADP/ATP carrier transport protons?
Yes, recent studies show that the carrier also transports protons, which is an integral part of its function.
How can I study ADP transport in the lab?
Common methods include Seahorse respirometry, radioactive transport assays, cryo-EM, and live-cell imaging with fluorescent sensors.
What is the role of SLC35B1 in ADP transport?
SLC35B1 mediates ATP/ADP translocation into the endoplasmic reticulum and is important for ER homeostasis.
Can CRISPR be used to study ADP transport?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the function of ADP transport genes.
Conclusion
ADP transport (GO:0015866) is a fundamental biological process that ensures the proper distribution of adenine nucleotides across cellular membranes. The mitochondrial ADP/ATP carrier is the archetypal ADP transporter, and its alternating-access mechanism, recently resolved by structural biology, explains how it exchanges ADP and ATP with high efficiency. Beyond mitochondria, transporters such as SLC35B1 extend ADP transport to the endoplasmic reticulum, highlighting the broad importance of this process. Dysregulation of ADP transport contributes to mitochondrial diseases, cancer, and neurodegeneration, making it a compelling target for therapeutic intervention. Continued research using CRISPR-based models and advanced imaging will further illuminate the molecular details and physiological roles of ADP transport.
References
- 1. Klingenberg M. 2008. The ADP and ATP transport in mitochondria and its carrier.. Biochim Biophys Acta 1778(10):1978-2021 PMID: 18510943
- 2. Kunji ER et al.. 2016. The transport mechanism of the mitochondrial ADP/ATP carrier.. Biochim Biophys Acta 1863(10):2379-93 PMID: 27001633
- 3. Bertholet AM et al.. 2019. H(+) transport is an integral function of the mitochondrial ADP/ATP carrier.. Nature 571(7766):515-520 PMID: 31341297
- 4. Ruprecht JJ et al.. 2019. The Molecular Mechanism of Transport by the Mitochondrial ADP/ATP Carrier.. Cell 176(3):435-447.e15 PMID: 30611538
- 5. Shechter E. 1986. [Secondary active transport].. Biochimie 68(3):357-65 PMID: 3017449
- 6. Gulati A et al.. 2025. Stepwise ATP translocation into the endoplasmic reticulum by human SLC35B1.. Nature 643(8072):855-864 PMID: 40399679
